Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Response Genetics Inc RGDXQ

Healthcare Technology Diagnostics & Research Scientific & Technical Instruments
Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available... see more

Recent & Breaking News (GREY:RGDXQ)

Cancer Genetics Announces Agreement in Principle to Acquire the Assets of Response Genetics, Inc. and Its Strong Franchise in Solid Tumor Molecular and Genomic Testing

GlobeNewswire August 10, 2015

Response Genetics Inc. Enters Into Asset Purchase Agreement With Cancer Genetics Inc.; Proposed Transaction to be Effectuated Through Voluntary Chapter 11; Business Uninterrupted

GlobeNewswire August 10, 2015

Great Basin Welcomes Kirk Calhoun to Board of Directors

PR Newswire June 2, 2015

Response Genetics, Inc. Announces First Quarter 2015 Financial Results

GlobeNewswire May 14, 2015

Response Genetics, Inc. to Release First Quarter 2015 Financial Results and Host Conference Call on May 14, 2015

GlobeNewswire May 7, 2015

Response Genetics, Inc. Announces Fourth Quarter and Year-End 2014 Financial Results

GlobeNewswire March 31, 2015

Response Genetics, Inc. to Release Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on March 31, 2015

GlobeNewswire March 19, 2015

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium 2015

GlobeNewswire January 15, 2015

Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber

PR Newswire December 12, 2014

Response Genetics Secures New York State Department of Health Approval for the Company's ResponseDX(R) Testing Services

GlobeNewswire December 11, 2014

Response Genetics, Inc. Announces Third Quarter 2014 Financial Results

GlobeNewswire November 13, 2014

Response Genetics, Inc. to Release Third Quarter 2014 Financial Results and Host Conference Call on November 13, 2014

GlobeNewswire November 6, 2014

Response Genetics Combines Cost-Effective, Rapid Turnaround Time With Next Generation Sequencing in Novel Lung Testing Offering

GlobeNewswire September 15, 2014

Response Genetics, Inc. to Serve as the Molecular Screening Center for ALCHEMIST

GlobeNewswire August 18, 2014

Response Genetics, Inc. Announces Second Quarter 2014 Financial Results

GlobeNewswire August 14, 2014

Response Genetics, Inc. to Release Second Quarter 2014 Financial Results and Host Conference Call on August 14, 2014

GlobeNewswire August 7, 2014

Response Genetics Secures $12.0 Million Credit Facility

GlobeNewswire August 5, 2014

Response Genetics Launches New Test for Cancer Immunotherapy Drug Development

GlobeNewswire June 16, 2014

FDA-Cleared, Medicare-Reimbursed, ResponseDX: Tissue of Origin(TM) Test Added to National Institute of Health's (NIH) Genetic Testing Registry

GlobeNewswire June 12, 2014

Response Genetics Expands Distribution of ResponseDX(R) Product Portfolio Into International Markets

GlobeNewswire May 14, 2014